1. Home
  2. STTK vs TCBX Comparison

STTK vs TCBX Comparison

Compare STTK & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.30

Market Cap

683.8M

Sector

Health Care

ML Signal

HOLD

Logo Third Coast Bancshares Inc.

TCBX

Third Coast Bancshares Inc.

HOLD

Current Price

$45.71

Market Cap

659.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
TCBX
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
683.8M
659.5M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
STTK
TCBX
Price
$7.30
$45.71
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
$10.00
$45.00
AVG Volume (30 Days)
1.3M
117.2K
Earning Date
05-01-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
36.33
EPS
N/A
1.97
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
$29.99
Revenue Next Year
N/A
$10.14
P/E Ratio
N/A
$23.10
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$35.73
52 Week High
$8.33
$45.58

Technical Indicators

Market Signals
Indicator
STTK
TCBX
Relative Strength Index (RSI) 54.26 73.60
Support Level $5.87 $36.41
Resistance Level $7.75 N/A
Average True Range (ATR) 0.52 1.07
MACD -0.03 0.14
Stochastic Oscillator 55.08 95.03

Price Performance

Historical Comparison
STTK
TCBX

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates twenty branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, one branch in Ballinger, Texas, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.

Share on Social Networks: